CN Patent

CN101611046A — 抗病毒的核苷类似物

Assigned to Biocryst Pharmaceuticals Inc · Expires 2009-12-23 · 16y expired

What this patent protects

本发明提供如本文所述的式(I)化合物，以及包含此化合物的药物组合物，和用于制备此化合物的合成方法和中间体。式(I)化合物用作抗病毒剂和/或抗癌药物。

USPTO Abstract

本发明提供如本文所述的式(I)化合物，以及包含此化合物的药物组合物，和用于制备此化合物的合成方法和中间体。式(I)化合物用作抗病毒剂和/或抗癌药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101611046A
Jurisdiction
CN
Classification
—
Expires
2009-12-23
Drug substance claim
No
Drug product claim
No
Assignee
Biocryst Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.